Search clinical trials for: Temisartan Amlodipine Rosuvastatin (Combination drug)

Total 5954 results

University of Hawaii
Queens Medical Center

Terminated

INvestigating TELmisartin Study (INTEL)

Covid19

United States
Boehringer Ingelheim

Completed

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

Hypertension

China
Boehringer Ingelheim
Bayer; GlaxoSmithKline

Completed

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Hypertension

United States, Canada
Bayer
Bang & Olufsen Medicom

Completed

Assessment of Compliance With Antihypertensive Telmisartan Therapy (COAST)

Hypertension

Poland, Slovakia
Boehringer Ingelheim

Completed

Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

Healthy
Servier Hellas Pharmaceuticals Ltd.

Completed

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination (CONTROL-3)

Hypertensive Disease | Adherence to Medication Regime

Greece
Samsung Medical Center

Recruiting

Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB (REVERSE-AR)

Aortic Valve Insufficiency

Korea, Republic of
Kiyuk Chang, MD,PhD

Recruiting

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI (ROSUZET-AMI)

Myocardial Infarction | Statin Adverse Reaction | HMG-CoA Reductase Inhibitor Toxicity

Korea, Republic of
Daping Hospital and the Research Institute of Surgery...
AstraZeneca

Unknown

Effect of Rosuvastatin Therapy on HDL2 Level

Coronary Heart Disease | Hyperlipemia

China
Korea University Anam Hospital

Completed

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

Coronary Artery Disease | Hypertension | Diabetes

Korea, Republic of
Boehringer Ingelheim

Completed

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Hypertension

China
Bayer

Completed

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension (METABOLIC)

Hypertension

Poland, Slovakia, Croatia, Slovenia
Kumamoto University
Japan Foundation for Aging and Health

Completed

A Trial of Telmisartan Prevention of Cardiovascular Disease (ATTEMPT-CVD)

Hypertension

Japan
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland (COUGH)

Hypertension

Poland
Medical University of Gdansk

Completed

The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

Proteinuria | Chronic Kidney Disease
Bayer
International Clinical Trials Association

Completed

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Arterial Hypertension

France
AstraZeneca

Completed

Assessment of the Effect of Food on ABT-143 Bioavailability

Pharmacokinetic Variables

United States
Merck KGaA, Darmstadt, Germany

Completed

Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

Hypertension

Germany
Novartis

Completed

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Hypertension

United States
Dr. Frank Behrens
Johann Wolfgang Goethe University Hospital

Recruiting

Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel) (PrevTel)

Neuropathic Pain | Chemotherapy Effect

Germany
Boehringer Ingelheim

Completed

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Obesity | Insulin Resistance

Italy, United States, Canada, Germany, Denmark
Bayer

Completed

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment (SONAR)

Hypertension

Romania, Slovakia
AstraZeneca

Completed

Interaction Between ABT-335, Rosuvastatin and Warfarin

Healthy

United States
Boehringer Ingelheim

Completed

Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

Hypertension
University of Pittsburgh
National Center for Research Resources (NCRR)

Completed

A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis

Pancreatitis

United States
Korea University Guro Hospital
Takeda Pharmaceuticals International, Inc.

Terminated

Manidipine Versus Amlodipine in Patients With Hypertension

Hypertension

Korea, Republic of
Sanofi

Completed

Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy (I-COMBINE)

Hypertension

Brazil, Chile, Colombia, Egypt, Lebanon, Mexico, Morocco, Tunisia, Venezuela
Nanjing First Hospital, Nanjing Medical University

Unknown

Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin (CROWN-1)

Acute Coronary Syndrome

China
Wuhan Union Hospital, China

Enrolling by invitation

An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

Hepatitis B, Chronic | Lipid Disorder

China
Radboud University Medical Center

Completed

Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

Endothelial Dysfunction | Ischemia Reperfusion Injury

Netherlands
Keun-Sik Hong
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Unknown

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Stroke, Ischemic

Korea, Republic of
Boehringer Ingelheim

Completed

Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

Healthy
Novartis

Completed

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Hypertension

India
Yaounde Central Hospital
University of Yaounde 1

Completed

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Cameroon
Boehringer Ingelheim

Completed

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Hypertension | Coronary Arteriosclerosis

Germany
Daiichi Sankyo, Inc.

Completed

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Hypertension | Type 2 Diabetes

United States
Novartis

Completed

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension (ASCENT)

Hypertension

United States
Assiut University

Not yet recruiting

Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Preeclampsia
AstraZeneca

Withdrawn

Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

PCI Patients
Tokyo Medical University

Unknown

Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

Intracranial Arterial Diseases

Japan
Shenyang Northern Hospital

Completed

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes (TRACK-D)

Diabetes Mellitus | Chronic Kidney Disease

China
AstraZeneca

Completed

Rosuvastatin ORBITAL Germany

Hypercholesterolemia
AstraZeneca

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Metabolic Syndrome | Dyslipidemia

Australia
University of Leipzig
AstraZeneca

Completed

Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure

Heart Failure

Germany
Hospital Pedro Hispano
Northwestern University

Completed

Rosuvastatin Affecting Aortic Valve Endothelium

Atherosclerosis | Hypercholesterolemia

Portugal
Elpen Pharmaceutical Co. Inc.

Completed

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT (PLATINUM)

Quality of Life | Dyslipidemias | Hyperlipidemias | Risk Factor, Cardiovascular

Greece
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

Blood Pressure | Renal Artery Obstruction | Glomerular Filtration Rate | Stents | Lipids

China
Second Affiliated Hospital of Soochow University
National Natural Science Foundation of China; AstraZeneca; Taicang No.1 People...

Unknown

Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) (REPAIRS)

Infarction, Anterior Cerebral Artery

China
UMC Utrecht

Withdrawn

Rosuvastatin for Hepatitis C

Hepatitis C

Netherlands
General University Hospital, Prague
University of Iowa; Loyola University Chicago; Ministry of Health, Czech Republic and other collaborators

Unknown

The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques (PREDICT)

Coronary Artery Disease

United States, Czech Republic

3

Subscribe